Skip to main content
Deutsch

Center for Cancer Research

Research from the laboratory to the patient and vice versa

Around 20 innovative research projects are initiated at the Center for Cancer Research every year. Due to the affiliation of the center to the Medical University of Vienna and the proximity to the AKH Wien (Vienna General Hospital), basic research and clinic can work together very closely and the research results flow directly into diagnosis and therapy.

Our vision: Cancer is a conquerable and curable disease!

10. January 2024

Possible trigger of chronic inflammatory bowel disease identified

As the cause of chronic inflammatory bowel diseases (IBD) such as Crohn's disease or ulcerative colitis is not yet known, treatment for sufferers is…
20. December 2023

Juliane Winkler successful in WWTF Life Sciences 2023 call "Understanding Biology with AI/ML"

Juliane Winkler from the Center for Cancer Research was successful with her submission to the Life Sciences 2023 Call "Understanding Biology with…
07. December 2023

FWF supports doctoral programs at the Medical University of Vienna

The Austrian Science Fund (FWF) awards grants within the 'doc.funds' and 'doc.funds.connect' programs to support doctoral programs, strengthening…
08. November 2023

Thomas Vogl takes up tenure-track assistant professorship at MedUni Vienna

Thomas Vogl starts a §99-(5) Assistant Professorship in “Microbiome in Cancer Immunology” under the tenure-track model at the Medical University of…
Cellular and Molecular Tumor Biology

Cellular and Molecular Tumor Biology

Investigation of the basic mechanisms leading to tumor development with particular emphasis on molecular cancer epidemiology, cancer cell signaling and therapy, mutagenesis, tumor-stroma interactions and the impact of inflammation on tumorigenesis. Read more

Mainly researched types of cancer

▪ colon cancer
▪ liver cancer
▪ osteosarcoma
▪ melanoma
Applied and Experimental Oncology

Applied and Experimental Oncology

Development and evaluation of novel anticancer compounds and/or therapy targets based on the precise elucidation of molecular factors underlying cancer development and progression. Elaboration of strategies to avoid therapy resistance against classical chemotherapy and novel targeted anticancer compounds. read more

Mainly researched types of cancer

▪ lung cancer and mesothelioma
▪ colon cancer
▪ breast cancer
▪ brain tumors (also in children)
▪ bladder carcinoma
▪ melanoma
▪ osteo- and soft tissue sarcomas
 Chemical Safety and Cancer Prevention

Chemical Safety and Cancer Prevention

Characterization of the toxicologic and carcinogenic potential of chemicals. Investigation of the complex cellular pathways by which cancer risk factors affect the multistep evolution of cancer. Elucidation of the molecular basis of therapy resistance. read more

Mainly researched types of cancer

▪ breast cancer
▪ liver cancer
▪ colon cancer
Tumor Progression and Metastasis

Tumor Progression and Metastasis

Identification and characterization of molecular mechanisms which promote tumor cells to invade into the surrounding tissue and into the circulation to form metastases. Examination of molecular mechanisms which educate cells of the tumor microenvironment such as cancer-associated fibroblasts and immune cells to facilitate metastatic colonization. read more

Mainly researched types of cancer

▪ liver cancer
▪ prostate cancer
▪ breast cancer

Scientific Services

Scientific Services

Equipped with the most modern devices and technologies, our facilities support scientists and students in their research work at the Center for Cancer Research. read more

Facilities

▪ FACS
▪ Microscopy & Imaging
▪ Cellculture
▪ Histology
▪ IT

Support cancer research

Help cure cancer In Austria, around 39,000 people are diagnosed with "cancer" every year. Unfortunately, the disease still leads to death in almost 50 percent of patients. With your donation you promote research and help to make cancer a curable disease. Donate now!
13. March 2024 12:30 PM-13:30 PM
CCR Technology Talk
27. March 2024 12:30 PM-13:30 PM
Progress Report: Paula Herek (Englinger/Berger lab)